Latest News & Features
Biotechnology
Yesterday’s UK Supreme Court decision in Kymab v Regeneron is expected to have profound implications for innovative life sciences companies, according to lawyers. 25 June 2020
article
In this unmissable keynote address, Charles will set out the work of the Medicines Patent Pool; How it works and what's proposed around COVID-19. Charles will seek to dispel some of the misinformation around licensing and explain how the MPP will serve to ensure a balance between the need to protect innovation and the need to fight a pandemic. 25 June 2020
Biotechnology
The UK Supreme Court today has sided with biopharmaceutical company Kymab, allowing its appeal in a suit involving Regeneron and patents covering transgenic mice. 24 June 2020
Americas
3M has settled with two companies it had accused of reselling N95 masks at inflated prices amid the COVID-19 pandemic. 23 June 2020
Big Pharma
The CJEU’s many attempts to clarify the law around SPCs has created more questions than answers, as Katie Cambrook and Ben Millson of Bristows explain. 23 June 2020
Americas
Mylan has succeeded in having a key Biogen patent covering multiple sclerosis drug Tecfidera invalidated by a US federal court. 23 June 2020
Americas
Roche Diabetes Care, a subsidiary of Switzerland-based Roche, has accused medical device company Insulet of infringing a patent covering a blood glucose level monitor. 22 June 2020
Big Pharma
The European Commission has backed voluntary IP licensing as part of its new vaccines strategy. 18 June 2020
Americas
MicroPort Orthopedics has sued rival Medacta, accusing it of providing surgeons with “knock-off copies and defaced versions” of MicroPort’s patented surgical tools. 18 June 2020
Big Pharma
Switzerland-based Novartis has failed to convince the UK Intellectual Property Office that a trademark applied-for by Boston Healthcare should not be registered. 18 June 2020